Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!

After Hitting Support, Vetr Issues Buy Rating On Bristol Myers

Courtesy of Benzinga.

The Vetr crowd on Wednesday upgraded its rating on Bristol-Myers Squibb Company (NYSE: BMY) from 3 stars (Hold), issued 12 days ago, to 3.5 stars (Buy). Crowd sentiment at the time of the upgrade was mostly positive, with 80 percent of Vetr user ratings bullish.

Shares price in the biotech comapny has remained in range for the better part of Q4, finding recent support around the $61 area. The stock reached that floor again Wednesday for the third time in the past month and finished the day at $61.20

See how crowdsourced ratings could help you time the market.

Currently, the Vetr crowd’s average price target on Bristol-Myers is up at $64.91, which is higher than the average analyst price target of $62.35. Less than 2 percent of Vetr users are holding BMY in their watch-lists.

Posted-In: VetrUpgrades Price Target Crowdsourcing Analyst Ratings General


Do you know someone who would benefit from this information? We can send your friend a strictly confidential, one-time email telling them about this information. Your privacy and your friend's privacy is your business... no spam! Click here and tell a friend!





You must be logged in to make a comment.
You can sign up for a membership or get a FREE Daily News membership or log in

Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!